from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2182c/-

LFCtreatmentdescriptionclass of inhibitor

1.804

Amikacinug/mL Amikacintranslation

1.400

Cap5-10ug/mL Capreomycintranslation

3.374

Rox10-50 ug/mL Roxithromycintranslation

-0.072

SM2-5 ug/mL Streptomycintranslation

1.990

Tet5-10 ug/mL Tetracyclinetranslation

-0.834

Rif0.2-5ug/mL Rifampicintranscription

-1.113

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.055

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.787

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.341

CPZ10-50 ug/mL Chlorpromazinerespiration

0.439

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.234

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.407

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.625

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.152

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.257

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.209

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.658

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.171

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.223

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.630

KCN5-20 ug/mL Potassium cyaniderespiration

0.318

NaN30.2-2 mM Sodium aziderespiration

0.953

Nigericin50 uM Nigericinrespiration

-0.005

TRC10-150 ug/mL Triclosanrespiration

0.695

TRZ10-25 ug/mL Thioridazinerespiration

0.016

Valinomycin0.5-10 uM Valinomycinrespiration

0.661

ZnSO42 mM ZnSO4respiration

0.770

menadione6-10 ug/mL Menadionerespiration

0.039

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.891

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.854

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.724

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.854

NRP_1Non-replicating persistence stage 1dosRassociated

-0.132

Amp0.2mg/mL AmpicillincellWall

-0.173

Cephalexin20-100 ug/mL CephalexincellWall

-0.517

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.047

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.614

EMB10-20 ug/mL EthambutolcellWall

0.365

Eta12-40 ug/mL EthionamidecellWall

0.748

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.273

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.805

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.090

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.503

BZA0.12 mg/mL BenzamidearomaticAmides

0.212

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.183

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.407

H2O24 mM hydrogen peroxideDNAdamaging

-0.323

Levo10 ug/mL LevofloxacinDNAdamaging

-0.603

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.479

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.055

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.453

UVUV-irradiationDNAdamaging

0.363

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.719

Antimycin12.5-50 ug/mL Antimycin A?

-0.700

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.762

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.004

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.259

PA8240.2-2 ug/mL PA-824?

0.228

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.035

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.568

Verapamil50 uM Verapamil?

-0.625

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.201

methoxatin10-20 ug/mL Methoxatin?